-
s P2Y12 Inhibitor or Aspirin Monotherapy in Patients with Coronary Artery Disease: is it Time for a Paradigm Shift?
- Source: Current Vascular Pharmacology, Volume 22, Issue 1, Jan 2024, p. 1 - 4
-
- 01 Jan 2024
- Previous Article
- Table of Contents
- Next Article
Preview this article:
P2Y12 Inhibitor or Aspirin Monotherapy in Patients with Coronary Artery Disease: is it Time for a Paradigm Shift?, Page 1 of 1
< Previous page Next page > /docserver/preview/fulltext/cvp/22/1/s2-1.gifThere is no abstract available.
© Bentham Science Publishers